2. Contents DuPont Investor Relations
1 2006 Summary
2 2006 At a Glance
4 Corporate Financial Data
Carl Lukach Karen Fletcher
Corporate Highlights
Vice President Director
Segment Information (302) 774-0001 (302) 774-1125
Consolidated Income Statements
Consolidated Balance Sheets
Consolidated Statements of Cash Flows
Selected Additional Data
14 DuPont Core Values,
Sustainability, and Six Sigma Laurie Conslato Jim Jacobson Pam Schools
Manager Manager Investor Relations
(302) 774-6088 (302) 774-0017 Coordinator
15 Industries, Regions, and Ingredients
(302) 774-9870
16 DuPont Science & Technology
18 Business Segments DuPont Data Book has been prepared to assist financial analysts, portfolio managers
and others in understanding and evaluating the company. This book presents graphics,
Agriculture & Nutrition
tabular, and other statistical data about the consolidated company and its business
Coatings & Color Technologies segments. The information presented in this book is generally included in—or can be
calculated from—previously issued press releases and published company reports on
Electronic & Communication Technologies Forms 10K, 10Q, and 8K. In particular, segment data is consistent with the 8K furnished
Performance Materials on April 4, 2007. Dollars are in millions except per share or where otherwise indicated.
Most notes to financial statements are not included. This information is only a summary
Safety & Protection and should be read in conjunction with the company’s audited consolidated financial
statements and “Management’s Discussion and Analysis,” which is located in the 2006
Pharmaceuticals
Form 10K filed with the Securities and Exchange Commission.
Use of Non-GAAP Measures
39 Major Global Sites and Principal Products This data book presents certain non-GAAP (U.S. generally accepted accounting
principles) measures that exclude significant items, including pretax operating income
(PTOI), PTOI margin, earnings, earnings per share, fixed costs as a percent of sales,
40 Major U.S. Sites and Principal Products base income tax rate, and return on invested capital (ROIC). Additional non-GAAP
measures include earnings before interest, taxes, and minority interests (EBIT), as
defined by the company, and earnings before interest, taxes, minority interests,
Inside Back Cover depreciation and amortization (EBITDA). Non-GAAP measures are not a substitute
for GAAP results. Significant items represent special charges or credits that are
Board of Directors and important to an understanding of the company’s ongoing operations. The company
uses non-GAAP measures to evaluate and manage the company’s operations.
DuPont Operating Team
The company believes that a discussion of results excluding special items provides
a useful analysis of ongoing operations. The determination of significant items may
not be comparable to similarly titled measures used by other companies.
A reconciliation of non-GAAP measures to GAAP results is provided on the Web at
www.dupont.com. For complete details of significant items, see DuPont’s quarterly
earnings news releases.
DuPont Data Book is available on the Web at www.dupont.com.
The DuPont Oval Logo, DuPont™, The miracles of science™, and all products denoted
Main Office Number: (302) 774-4994
with ™ or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and
Fax: (302) 773-2631 Company or its affiliates.
Internet: www.dupont.com April 2007
3. 2006 Summary
EPS* ROIC**
NetSales
Net Sales EPS* ROIC**
Executing Growth Strategies Pretax Operating Income Margin1
and Delivering Results
nds) (dollars) (percentage) (percentage)
(dollars in thousands) (dollars) (percentage)
(dollars in billions) (percentage)
$3.00 20% 20%
$30 $3.00 20%
In 2006, we remained focused on executing
our three growth strategies and our $25 $2.50
$2.50
15%
15% 15%
productivity initiatives. As a consequence,
$20 $2.00
$2.00
we delivered strong results:
• Average selling prices increased in each $15 $1.50 10%
$1.50 10% 10%
quarter compared with the prior year, partially
$10 $1.00
$1.00
due to the launch of more than 1,100 new 5%
5% 5%
products. This was the third consecutive year $5 $.50
$.50
in which we improved pricing.
2005• 2006 costs as a percent of sales declined 2006
Fixed 2002 2003 2004 2005 2006 2002 2003 2004 2005 2006 2002
2003 2004 2002 2003 2004 2005 2002 2003 2004 2005 2006 2002 2003 2004 2005 2006
Interiors, which was divested quarter versus the prior year,
in each Textiles & Interiors, which was divested
representing the third successive year of in 2004
cost productivity gains.
Net Sales EPS* ROIC**
• Pretax operating Sales (PTOI) margin
Net income EPS* ROIC**
Earnings Per Share1 Return on Invested Capital1, 2
increased 70 basisthousands) (bps) to 16.3 percent.
(dollars points
(dollars in in thousands) (dollars) (percentage) (percentage)
(dollars) (percentage) (percentage)
(dollars) (percentage)
• Earnings per share (EPS) increased 63
$30 $3.00 20% 20%
$30 $3.00 20% 20%
percent to $3.38. Excluding significant items,
$25 $2.50
$25 $2.50
EPS grew 23 percent to $2.88. 15% 15%
15% 15%
$20 $2.00
• Return on invested capital (ROIC) increased
$20 $2.00
700 bps to 18 percent. Excluding the impact
$15 $1.50
$15 $1.50 10% 10%
10% 10%
of SFAS No. 158 and significant items, ROIC
improved 300 $10 to 16 percent.
bps
$10 $1.00
$1.00
5% 5%
5% 5%
$5$5 $.50
$.50
Growth Strategies 2004 2005 2006
2002 2003 2002 2003 2004 2005 2006 2002 2003 2004 2005 2006 2002
2002 2003 2004 2005 2006 2002 2003 2004 2005 2006 2002 2003 2004 2005 2006 2002
OurTextiles && Interiors, which was divested
Science to Work was divested
Textiles Interiors, which
• Put 1 Before significant items
inin 2004
2004
2 xcludes the effect of adopting SFAS No. 158
E
• Go Where the Growth Is
• Leverage the Power of
One DuPont November 2005 Action Items 2006 Results
Increase fixed cost productivity – Ahead of plan
– Fixed costs as percent of sales
On Track—Initiatives to down 200 bps
Enhance Shareholder Value Improve return on capital – On track
– ROIC increased 300 bps
In November 2005, DuPont announced a
four-part plan to enhance shareholder value: Accelerate return on innovation – On track
– Sales from new products
• Increase fixed cost productivity
accounted for 34 percent of total
• Improve return on capital
company revenues
• Accelerate return on innovation and
– Pipeline advances
• Repurchase $5 billion, or about 12 percent, – Commercialize bio-based materials
of our shares.
Repurchase shares – On track
– Repurchased $3.3 billion with
We are on track with these initiatives.
remaining $1.7 planned for
completion by December 2007
2006 DuPont Data Book
4. DuPont 2006 At a Glance
In 2006, DuPont remained focused on its three growth strategies—put science to work, go where the growth is, and leverage the
power of One DuPont. It was a successful year marked by strong financial performance, exciting scientific and business developments,
and promising growth.
DuPont named three new executive
January April
vice presidents—Thomas M. Connelly,
DuPont announced that its DeLisle, DuPont and Syngenta announced a joint
Jeffrey L. Keefer, and Ellen J. Kullman.
Mississippi, titanium dioxide plant venture and licensing agreement that
resumed operations less than five months will provide North American farmers
DuPont and BP announced plans to
after a direct hit from Hurricane Katrina. with broader access to the companies’
develop, produce, and market biobutanol,
proprietary corn and soybean genetics
a next generation biofuel, to help meet
February and biotechnology traits.
increasing global demand for renewable
The Department of Commerce’s United
transportation fuels.
DuPont formed a new business unit—
States Patent Trademark Office awarded
DuPont Biofuels—to accelerate com-
U.S. Patent No. 7 million to DuPont senior
July
mercialization of the company’s biofuels
researcher Dr. John P. O’Brien for inventing
DuPont completed an enhanced flood wall
technologies and pipeline candidates.
polysaccharide fibers, which are cotton-
at its DeLisle titanium dioxide plant ahead
like fibers derived from biologically based
of schedule and under budget.
May
renewable resources.
DuPont began construction of a new
DuPont announced it will begin production
DuPont and Syngenta announced a crop world-class coatings plant in the Jiading
of an innovative high-performance
protection technology exchange. Syngenta district of Shanghai. When completed,
material with DuPont™ Kevlar® that
acquired an exclusive worldwide license to it will serve a variety of automotive and
will offer breakthroughs in a range of
develop DuPont’s insecticide Rynaxypyr™. industrial markets in China.
rubber-based products.
DuPont acquired worldwide rights to
The United Nations’ Food and Agriculture
DuPont Electronic Technologies
Syngenta’s fungicide Acanto®.
Organization asked DuPont to provide
established a semiconductor materials
initial supplies of DuPont™ Virkon® S
technical center in Taiwan, establishing
March
veterinary disinfectant to 69 nations to
advanced semiconductor materials
DuPont announced it will brand its new
prevent avian flu from spreading.
capabilities near its customers.
glyphosate, ALS-tolerant trait Optimum™
GAT™. This trait is targeted for
June August
commercialization later in the decade
The company opened the DuPont Korea
The company announced plans to expand
for multiple crops.
Technology Center to support research
two of its North American seed research
DuPont Coatings Color Technologies and development needs of fast growing
facilities, increasing the speed at which
launched a global plan to reduce costs, major industries in Asia, including
the company can bring enhanced
improve productivity, and better serve its electronics, automotive, and construction.
products to market.
customers in its performance coatings
DuPont and Alcoa introduced Reynobond®
DuPont amended its U.S. defined benefit
businesses. The segment will consolidate
with Kevlar®, a durable architectural panel
pension plan and its employee savings
facilities and rebalance assets to faster
system designed to withstand wind-borne
plan, largely effective January 2008. These
growing markets and geographies. These
debris and wind speeds common in hur-
steps are consistent with market trends in
actions are anticipated to reduce annual
ricanes up to a Category 3 storm.
employee benefits and will enhance the
costs by $165 million.
company’s business competitiveness.
DuPont introduced Spallshield®, a plastic
The Ceres Report ranked DuPont first in
composite that provides up to eight times
the United States and second globally on
the impact performance of standard
climate change, citing DuPont’s greenhouse
laminated automotive glass.
gas reduction, its climate-related new prod-
ucts, and its corporate sustainability goals.
2
5. Photos: (Left) DuPont is working
to develop new biofuels. (Middle)
DuPont is helping farmers increase
yield. (Right) DuPont™ Nomex® and
Kevlar® protect firefighters.
DuPont announced a multiproduct, DuPont was recognized by the U.S. DuPont met an important milestone
multiregion expansion plan for its high- Environmental Protection Agency as one toward the commercialization of its
performance Nomex® brand fiber that of the 25 largest green power purchasers. Optimum™ GAT™ trait by completing
will deliver a step change increase in U.S. regulatory submissions for approval
The company announced broader sustain-
worldwide capacity. The company will of the trait in soybeans. The company said
ability commitments and said it expects to
invest more than $100 million in the it expected commercialization of soybean
derive additional revenues of $6 billion or
three-part expansion that is scheduled products containing the trait by 2009.
more by 2015 from its safety, environment,
to begin late in 2006.
energy, and climate efforts.
December
DuPont introduced Hybrid Membrane
DuPont announced an agreement with DuPont Engineering Polymers broke
Technology for significantly improved
Zhangjiagang Glory Chemical Industry Co., ground in Singapore for new production
air and liquid filtration that will fill the
Ltd. to produce and distribute bio-based facilities for one of its highest growth
performance gap between traditional
DuPont™ Sorona® polymer throughout Asia. businesses—DuPont™ Vespel® parts
nonwovens and microporous films.
and shapes.
November
September DuPont Agriculture Nutrition launched
DuPont introduced DuPont™ Tyvek®
Nobel Laureates and professors of a plan to increase investment in plant
ThermaWrap™, a breathable, metallized
chemistry Drs. Robert H. Grubbs and genetics, biotechnology, and other high-
housewrap designed to enhance the
Richard R. Schrock—recipients of the value growth opportunities, while further
thermal performance of walls.
2005 Nobel Prize for Chemistry for improving competitiveness in low-growth
DuPont launched DuPont™ Premium
the development of olefin metathesis— areas of its nutrition and crop protection
Interior Air Filters, a new automotive
celebrated the contributions of Dr. Herbert businesses, by reducing operating costs
filtering technology that cleans the
S. Eleuterio, a retired DuPont chemist who about $100 million a year.
outside air before it enters the cabin
was instrumental in the early development
DuPont met an important milestone
of the automobile.
of this technology.
toward the commercialization of its
DuPont said its subsidiary Pioneer Hi-Bred
DuPont received a 2006 Secretary of proprietary high oleic soybean oil trait by
International, Inc. delivered strong product
Defense Employer Support Freedom Award completing U.S. regulatory submissions.
performance from its seed products in
from the U.S. Department of Defense. The company remains on track for 2009
the 2006 North American harvest and commercialization of products containing
DuPont was named one of the 100 Best
continued to expand its share in Brazil. the trait.
Companies for working mothers.
DuPont Tate Lyle BioProducts, LLC,
October a 50 – 50 joint venture of DuPont and
DuPont and Broin announced a partner- Tate Lyle, announced the first
ship to advance the development of commercial shipments of Bio-PDO™
cellulosic ethanol. from its $100 million facility in Loudon,
Tennessee, making it the first in the
The company launched DuPont™ Tyvek®
world to manufacture this new
AtticWrap™, the first breathable roofing
bio-based product.
membrane that prevents air and water
intrusion and helps conserve energy.
2006 DuPont Data Book
6. Corporate Financial Data
Corporate Highlights
(dollars in millions, except per share)
2005
2006
Net sales $26,639
Operating Results $27,421
Income 1 2,056
3,148
Net income (loss) 2,056
3,148
Income before significant items 1 2,332
2,685
Depreciation 1,128
1,157
EBIT 3,884
3,667
EBITDA 5,209
5,019
Cash provided by operating activities 2,542
3,736
Capital expenditures 1,406
1,563
Research and development expense 4 1,336
1,302
Total assets $33,291
Financial Position, $31,777 5
Working capital 4,986
Year End 4,930
Total debt 8,180
7,530
Stockholders’ equity 8,962
9,422 5
Income 1, 7 $2.07
Data Per Common Share $3.38
Net income (loss) 7 $2.07
$3.38
Income before significant items 1, 7 $2.34
$2.88
Dividends $1.46
$1.48
Market price – Year-end close $42.50
$48.71
High-low range $54.90 – $37.60
$49.68 – $38.52
Book value at year-end $9.49
$9.96
Average number of shares (millions) – diluted 989
929
Shares outstanding – year-end (millions) 920
922
Total stockholder return (10.4)%
Ratios 18.1%
Dividend yield 3.4%
3.0%
Share price increase (decrease) (13.4)%
14.6%
P/E on income before significant items 1, 8 18
17
Dividend payout, as percentage of earnings per share
before significant items 1 62.4%
51.4%
Return on average stockholders’ equity before significant items 1 20.5%
27.8%
Return on average investors’ capital before significant items 1 12.7%
15.9%
Asset turnover ratio 80%
86%
Cash provided by operating activities as a percentage of total debt 31.1%
49.6%
Debt to total capital 6 46.4%
43.3%
Interest coverage ratio 10 11.1
9.1
Current ratio 6 1.7
1.6
Exchange loss – net of tax $ (38)
$ (30)
Number of employees – year-end (thousands) 60
Employees 59
1 efore cumulative effect of changes in accounting principles.
B 6 ncludes related assets and/or liabilities classified as held for sale within the
I
2 ncludes a cumulative effect of a change in accounting principle charge of $29 and $0.03
I Consolidated Balance Sheets.
per share (diluted). 7 iluted, based on average number of common shares.
D
3 ncludes a cumulative effect of a change in accounting principle charge of $2,944 and
I 8 ased on year-end share price.
B
$2.95 per share (diluted). 9 atio excludes increase in tax payments related to sale of DuPont Pharmaceuticals.
R
4 xcludes purchased in-process research and development.
E 10 ncome before significant items and income taxes, plus the sum of interest expense
I
5 n December 31, 2006, the company adopted Statement of Financial Accounting
O and amortization of capitalized interest less interest income, divided by the sum of
Standards No. 158,“Employers’ Accounting for Defined Benefit Pension and Other interest expense and capitalized interest less interest income.
Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106 and 132(R).”
Total assets and stockholders’ equity were reduced by $2,159 and $1,555, respectively,
as a result of such adoption.
7. 2004 2003 2002 Cash Provided By Cash Returned to Shareholders
Operating Activities
$27,340 $26,996 $24,006
1,780 (dollars) 1,002 1,841 (dollars in millions)
(dollars in millions)
1,780 973-2 (1,103) 3 $5,000
$3.00 $3,750
2,393 1,669 2,009
$2.50
1,124 1,355 1,297 $4,000
$3,000
1,687 407 2,343
$2.00
$3,000
$2,250
3,000 1,938 3,799
$1.50
3,231 2,589 2,439 $2,000
$1,500
1,298 $1.00 1,784 1,416
1,333 1,349 1,264 $750 $1,000
$0.50
$35,632 $37,039 $34,621
7,272 5,419 6,363
2002 2003 2004 2005 2006 2002 2003 2004 2005 2006 2002 2003 2004 2005 2006
6,485-6 10,479-6 6,832
11,377 9,781 9,063 Dividends
Share Repurchase
$1.77 $0.99 $1.84
$1.77 $0.96-2 $(1.11)-3
Five Year Sources and Uses of Cash 2002–2006
$2.38 $1.66 $2.00
$1.40 $1.40 $1.40 (dollars in billions)
$49.05 $45.89 $42.40 Cash From Operations
$49.39 – $39.88 $46.00 – $34.71 $49.80 – $35.02
Asset Sales
$11.20 $9.57 $8.88
1,003 1,000 999 Net Debt Increase
994 997 994 Other
9.9% 11.5% 3.0% Capex Investment in Affiliates
2.9% 3.1% 3.3% Dividends
6.9% 8.2% (0.3)%
Share Repurchases
21 28 21
Acquisitions
58.8% 84.3% 70.0% Redemption of Minority Interests
23.0% 17.9% 17.4% Other
12.3% 9.0% 10.6%
77% 73% 69% -$10 -$5 $0 $5 $10 $15
49.8% 24.7% 65.1%-9
34.2% 50.3% 37.3%
Five-Year Performance 2002–2006
11.5 7.9 9.7
1.9 1.2 1.9
Stockholder Return DuPont SP 500
$ (51) $ (3) $ (99)
Dividend Yield1 3.14% 1.71%
60 81 79
Share Price Annual Appreciation 2.76% 4.32%
2
Total Annual Return 6.23% 6.19%
2, 3
Dividend Growth 1.12% 9.13%
2
Ten-Year Performance 1997–2006
Stockholder Return DuPont SP 500
Dividend Yield1 2.86% 1.52%
Share Price Annual Appreciation2 0.35% 6.71%
Total Annual Return2, 3 3.31% 8.42%
Dividend Growth 1.87% 4.85%
2
1 Average annual dividend yield based on year-end stock price over the period shown.
2 Compound annual growth rate over the period shown.
3 Includes reinvestment of dividends.
2006 DuPont Data Book
8. Corporate Financial Data
Segment Information
(dollars in millions)
2005 2004
2006
Segment Sales 1
Agriculture Nutrition $ 6,090 $ 5,939
$ 6,008
Coatings Color Technologies 6,055 5,839
6,290
Electronic Communication Technologies 3,408 3,138
3,573
Performance Materials 6,062 5,863
6,179
Safety Protection 5,144 4,632
5,496
N/A
Textiles Interiors N/A 2,319
Other 174 163
180
Total segment sales 26,933 27,893
27,726
Elimination of transfers (294) (553)
(305)
Net sales $26,639 $27,340
$27,421
Segment Pretax Operating Income – Before Significant Items
Agriculture Nutrition $ 875 $ 818
$ 725
Coatings Color Technologies 649 814
827
Electronic Communication Technologies 510 377
572
Performance Materials 523 623
636
Pharmaceuticals 751 681
819
Safety Protection 1,016 914
1,107
Textiles Interiors N/A N/A 124
Other (129) (146)
(173)
Total segment pretax operating income – before significant items 4,195 4,205
4,513
Exchange gains (losses) 445 (411)
(4)
Corporate expenses and interest (1,049) (932)
(1,047)
Income before significant items, income taxes, and minority interests 2 3,591 2,862
3,462
Net significant items 3 (28) (1,420)
(133)
Income before income taxes and minority interests 2 $ 3,563 $ 1,442
$ 3,329
1 Sales include transfers.
2 Before cumulative effect of changes in accounting principles.
3 For complete details of significant items, see DuPont’s quarterly earnings news releases.
DuPont’s Share of After Tax
Equity Affiliate Earnings
2005 2004
2006
Equity Affiliate Analysis
Agriculture Nutrition $ (3) $ (5)
$ (3)
Coatings Color Technologies 1 3
0
Electronic Communication Technologies 36 27
44
Performance Materials 21 (100)1
9
Safety Protection 18 13
20
Textiles Interiors N/A 71
N/A
Other 10 (2)
(5)
Total segments $ 83 $ 7
$ 65
1 Includes a charge of $150 for antitrust litigation matters associated with DuPont Dow Elastomers LLC which was accounted for as an equity affiliate until April 30, 2004.
6
9. 2005
2006
1st 2nd 3rd 4th
1st 2nd 3rd 4th Full Yr. Full Yr.
Segment Sales 1
Agriculture Nutrition $ 2,290 $2,021 $ 912 $ 867 $ 6,090
$ 2,174 $1,935 $ 885 $ 1,014 $ 6,008
Coatings Color Technologies 1,494 1,592 1,497 1,472 6,055
1,478 1,625 1,612 1,575 6,290
Electronic Communication Technologies 885 811 907 861 829 3,408
942 892 854 3,573
Performance Materials 1,611 1,665 1,378 1,408 6,062
1,541 1,556 1,559 1,523 6,179
Safety Protection 1,262 1,366 1,247 1,269 5,144
1,360 1,413 1,385 1,338 5,496
Other 41 42 43 48 174
46 48 47 39 180
$ 7,509
Total segment sales $7,593 $5,938 $5,893 $26,933
$ 7,484 $7,519 $6,380 $6,343 $27,726
Segment Pretax Operating Income –
Before Significant Items
Agriculture Nutrition $ 763 $ 514 $ (135) $ (267) $875
$ 597 $ 430 $ (154) $ (148) $725
Coatings Color Technologies 162 190 142 155 649
156 228 238 205 827
Electronic Communication Technologies 108 164 145 93 510
160 168 132 112 572
Performance Materials 207 186 78 52 523
155 191 169 121 636
Pharmaceuticals 159 192 197 203 751
169 200 210 240 819
Safety Protection 233 286 282 215 1,016
268 308 286 245 1,107
Other (24) (34) (16) (55) (129)
(56) (32)
(31) (54) (173)
Total segment pretax operating
4,513
income – before significant items 1,449 1,608 1,498 693 396 4,195
1,493 850 721
Exchange gains and losses 111 183 71 80 445
(18) 26 (3) (9) (4)
Corporate expenses and interest (225) (240) (266) (318) (1,049)
(253) (264) (261) (269) (1,047)
3,462
Income before significant items 2 1,494 1,441 498 158 3,591
1,178 1,255 586 443
Pretax Impact of Significant Items 2
–
Restructuring activities – – – – –
(135) – (194) (329)
–
Hurricane insurance proceeds – – – – –
– 50 93 143
Corporate tax – related items – 28 – – 28
7 – – 90 97
– –
Asbestos insurance recoveries – – – – –
– 61 61
Sale terms and expense
accrual changes – – – – –
– – – (58) (58)
– – –
Impairment loss on asset held-for-sale – – – – –
(47) (47)
– – –
Hurricane losses – – (146) – (146)
– –
Sale of Photomasks stock – 48 – – 48
– – – – –
Textiles Interiors – related items – 39 – – 39
– – – – –
DDE – related items – 3 – – 3
– – – – –
Net impact of significant items – 118 (146) – (28)
(128) – 50 (55) (133)
Income before income taxes and
minority interests $ 1,494 $ 1,559 $ 352 $ 158 $ 3,563
$ 1,050 $ 1,255 $ 636 $ 388 $ 3,329
2005
2006
1st 2nd 3rd 4th
1st 2nd 3rd 4th Full Yr. Full Yr.
Earnings Per Share of
Common Stock – Diluted 3
Income before significant items $ 0.96 $ 0.90 $ 0.33 $ 0.13 $ 2.34
$ 0.93 $ 1.01 $ 0.49 $ 0.45 $ 2.88
Significant items 0.00 0.11 (0.42) 0.03 (0.27)
(0.05) 0.03 0.03 0.49 0.50
Income (loss) $ 0.96 $ 1.01 $ (0.09) $ 0.16 $ 2.07
$ 0.88 $ 1.04 $ 0.52 $ 0.94 $ 3.38
1 Sales include transfers.
2 For complete details of significant items, see DuPont’s quarterly earnings news releases.
3 arnings per share for the year may not equal to sum of quarterly earnings per share due to changes in average share calculations.
E
2006 DuPont Data Book
10. Corporate Financial Data
Consolidated Income Statements
(dollars in millions, except per share)
For the year ended December 31 2005 2004 2003 2002
2006
Net sales $26,639 $27,340 $26,996 $24,006
$27,421
Other income, net 1 1,852 655 734 516
1,561
Total 28,491 27,995 27,730 24,522
28,982
Cost of goods sold and other operating charges 19,683 20,827 20,742 17,819
20,440
Selling, general and administrative expenses 3,223 3,141 3,067 2,763
3,224
Amortization of intangible assets 230 223 229 218
227
Research and development expense 1,336 1,333 1,349 1,264
1,302
Interest expense 518 362 347 359
460
Separation activities – Textiles Interiors (62) 667 1,620 –
–
Goodwill impairment – Textiles Interiors – – – 295 –
Gain on sale of interest by subsidiary – nonoperating – – – (62) –
Gain on sale of DuPont Pharmaceuticals – – – – (25)
Total 24,928 26,553 27,587 22,398
25,653
Income before income taxes and minority interests 3,563 1,442 143 2,124
3,329
Provision for (benefit from) income taxes 1,470 (329) (930) 185
196
Minority interests in earnings (losses) of
consolidated subsidiaries 37 (9) 71 98
(15)
Income before cumulative effect of changes in
2,056 1,780 1,002 1,841
accounting principles 3,148
Cumulative effect of changes in accounting principles,
net of income taxes – – – (29) (2,944)
Net income (loss) $ 2,056 $ 1,780 $ 973 $ (1,103)
$ 3,148
Diluted earnings per share of common stock
Income before cumulative effect of
changes in accounting principles $ 2.07 $ 1.77 $ 0.99 $ 1.84
$ 3.38
Cumulative effect of changes in accounting principles – – – (0.03) (2.95)
Net income (loss) $ 2.07 $ 1.77 $ 0.96 $ (1.11)
$ 3.38
1 Other income, net:
$ 747 $ 675 $ 573 $ 469
$ 815
Cozaar®/Hyzaar® licensing income
130 151 141 128
120
Royalty income
244 188 70 97
219
Interest income, net of miscellaneous interest expense
108 (39) 10 36
50
Equity in earnings (losses) of affiliates
82 28 17 30
55
Net gains on sales of assets
423 (391) (134) (294)
16
Net exchange gains (losses)
118 43 57 50
286
Miscellaneous income and expenses – net
$ 1,852 $ 655 $ 734 $ 516
$ 1,561
Total Other income, net
11. Consolidated Balance Sheets
(dollars in millions)
December 31 2005 2004 2003 2002
2006
Assets
Current assets
Cash and cash equivalents $ 1,736 $ 3,369 $ 3,273 $ 3,678
$ 1,814
Marketable debt securities 115 167 25 465
79
Accounts and notes receivable, net 4,801 4,889 4,218 3,884
5,198
Inventories 4,743 4,489 4,107 4,409
4,941
Prepaid expenses 199 209 208 175
182
Income taxes 828 1,557 1,141 848
656
Assets held for sale – 531 5,490 –
–
Total current assets 12,422 15,211 18,462 13,459
12,870
Property, plant and equipment 24,963 23,978 24,149 33,732
25,719
Less: Accumulated depreciation 14,654 13,754 14,257 20,446
15,221
Net property, plant and equipment 10,309 10,224 9,892 13,286
10,498
Goodwill 2,087 2,082 1,939 1,167
2,108
Other intangible assets 2,684 2,848 2,986 3,109
2,479
Investment in affiliates 844 1,034 1,304 2,047
803
Other assets 4,945 4,233 2,456 1,553
3,019
Total $33,291 $35,632 $37,039 $34,621
$31,7771
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable $ 2,670 $ 2,661 $ 2,341 $ 2,636
$ 2,711
Short-term borrowings and capital lease obligations 1,397 936 5,914 1,185
1,517
Income taxes 294 192 60 47
178
Other accrued liabilities 3,075 4,054 3,034 3,228
3,534
Liabilities held for sale – 96 1,694 –
–
Total current liabilities 7,436 7,939 13,043 7,096
7,940
Long-term borrowings and capital lease obligations 6,783 5,548 4,301 5,647
6,013
Other liabilities 8,441 8,692 8,909 9,829
7,692
Deferred income taxes 1,179 966 508 563
269
Total liabilities 23,839 23,145 26,761 23,135
21,914
Minority interests 490 1,110 497 2,423
441
Stockholders’ equity 8,962 11,377 9,781 9,063
9,4221
Total $33,291 $35,632 $37,039 $34,621
$31,777
1 On December 31, 2006, the company adopted Statement of Financial Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans,
an amendment of FASB Statements No. 87, 88, 106 and 132(R).” Total assets and stockholders’ equity were reduced by $2,159 and $1,555, respectively, as a result of such adoption.
2006 DuPont Data Book